Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Aug 30, 2024

SELL
$5.87 - $7.85 $1,467 - $1,962
-250 Closed
0 $0
Q2 2021

Aug 30, 2024

BUY
$6.69 - $9.0 $1,672 - $2,250
250 New
250 $1.87 Million
Q1 2021

Aug 30, 2024

BUY
$8.26 - $11.4 $2,065 - $2,850
250 New
250 $2.07 Million

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $2.51B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.